13 employees
Rarecells Inc. is a healthcare company focused on the development and commercialization of non-invasive Early Cancer Detection tests.
2010
$8M
from 2 investors over 2 rounds
Rarecells Diagnostics raised $8M on July 22, 2021
Investors: AA & SONS and Globivest